Hatipoğlu Osman Nuri, Perinçek Gökhan, Cakır Edis Ebru, Tabakoğlu Erhan, Altıay Gündeniz
Trakya Universitesi Tıp Fakultesi, Göğüs Hastalıkları Anabilim Dalı, Edirne.
Tuberk Toraks. 2010;58(3):268-77.
Massive pulmonary embolism (MPE) is a life threatening disease, thrombolytic treatment could save lives. The aims of this study are to identify early and late mortality rates in patients with MPE who received thrombolytic treatment, and mortality related risk factors. All the hospital records for the MPE patients who received thrombolytic treatment between 1998 and 2006 were retrospectively investigated. Pulmonary embolism was diagnosed through computed tomografi scan and V/P scintigraphy. Due to MPE, 21 women total 41 patients who undergo tPA or streptokinase were included in the study. Kaplan-Meier for the survival analysis and cox regression analysis for determining the mortality related independent risk factors were used. Dying while staying in hospital was accepted as early or hospital mortality, after discharge from hospital as late mortality. Out of 41 patients, 12 of them died while they are hospitalized (hospital mortality; 29%) 6 of them died after they were discharged (late mortality; 21%). The average survival time among discharged patients was 2304 days (95% confidence interval: 1725-2884). Among those patients who took streptokinase or tPA, late or early mortality rates (p> 0.05) and survival time did not show significant difference (p= 0.8908). The presence of arrhythmia [p= 0.01; odds rate (OR): 6.25] and jugular vein distention (JVD) (p= 0.03; OR: 6.25) for hospital mortality and multiple ongoing health problems for the late mortality were identified as the independent risk factors. For the hospital mortality, the presence of JVD or arrhythmia, for prognostic sensitivity, specificity, positive predictive value and negative predictive value were recorded as 75%, 79%, 60% and 88% respectively. In conclusion, the presence of arrhythmia and/or JVD on a patient with MPE is a negative prognostic factor for hospital mortality. The presence of other ongoing health problems influences the survival time of the discharged patients.
大面积肺栓塞(MPE)是一种危及生命的疾病,溶栓治疗可挽救生命。本研究的目的是确定接受溶栓治疗的MPE患者的早期和晚期死亡率,以及与死亡率相关的危险因素。对1998年至2006年间接受溶栓治疗的MPE患者的所有医院记录进行了回顾性调查。通过计算机断层扫描和V/P闪烁扫描诊断肺栓塞。由于MPE,共有41例接受tPA或链激酶治疗的患者(其中21名女性)被纳入研究。采用Kaplan-Meier法进行生存分析,采用Cox回归分析确定与死亡率相关的独立危险因素。住院期间死亡被视为早期或医院死亡率,出院后死亡被视为晚期死亡率。41例患者中,12例在住院期间死亡(医院死亡率;29%),6例在出院后死亡(晚期死亡率;21%)。出院患者的平均生存时间为2304天(95%置信区间:1725-2884)。在接受链激酶或tPA治疗的患者中,晚期或早期死亡率(p>0.05)和生存时间未显示出显著差异(p=0.8908)。心律失常的存在[p=0.01;比值比(OR):6.25]和颈静脉扩张(JVD)(p=0.03;OR:6.25)是医院死亡率的独立危险因素,多种并存的健康问题是晚期死亡率的独立危险因素。对于医院死亡率,JVD或心律失常的存在,其预后敏感性、特异性、阳性预测值和阴性预测值分别记录为75%、79%、60%和88%。总之,MPE患者出现心律失常和/或JVD是医院死亡率的不良预后因素。其他并存健康问题的存在影响出院患者的生存时间。